1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Products and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Increasing Adoption Rate of Infusion Pumps 6.1.2 Rapid Technological Advancements 6.1.3 Rising Incidences of Chronic Disease 6.1.4 Increasing Adoption of Infusion Pumps in Home Care Settings 6.2 Market Restraints 6.2.1 High Price of Infusion Pumps 6.2.2 Safety Issues Associated with Infusion Pumps 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Product Type 7.1.1 By Infusion Pump Types 7.1.1.1 Ambulatory Infusion Pumps 7.1.1.2 Syringe Infusion Pumps 7.1.1.3 Volumetric Infusion Pumps 7.1.1.4 Insulin Infusion Pumps 7.1.1.5 Enteral Infusion Pumps 7.1.1.6 Others 7.1.2 By Accessories/Disposables 7.2 By Applications 7.2.1 Gastroenterology 7.2.2 Diabetes 7.2.3 Analgesia/Pain Management 7.2.4 Hematology 7.2.5 Others 7.3 By End-users 7.3.1 Hospitals 7.3.2 Ambulatory Surgical Centers 7.3.3 Home Care Settings 7.3.4 Others 7.4 By Geography 7.4.1 North America 7.4.1.1 United States 7.4.1.2 Canada 7.4.1.3 Mexico 7.4.2 Europe 7.4.2.1 France 7.4.2.2 Germany 7.4.2.3 United Kingdom 7.4.2.4 Italy 7.4.2.5 Spain 7.4.2.6 Rest Of Europe 7.4.3 Asia-Pacific 7.4.3.1 China 7.4.3.2 Japan 7.4.3.3 India 7.4.3.4 Australia 7.4.3.5 New Zealand 7.4.3.6 South Korea 7.4.3.7 Rest of Asia-Pacific 7.4.4 Middle East & Africa 7.4.4.1 GCC 7.4.4.2 South Africa 7.4.4.3 Rest of Middle East & Africa 7.4.5 South America 7.4.5.1 Brazil 7.4.5.2 Argentina 7.4.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers and Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Product Launches 9. Key Players 9.1 B. Braun Melsungen AG 9.2 Baxter International Inc. 9.3 Becton, Dickinson, and Company 9.4 CareFusion Corporation 9.5 F. Hoffmann-la Roche Ltd. 9.6 Johnson & Johnson 9.7 Medtronic Inc. 9.8 Pfizer Inc. 9.9 Smiths Medical 9.10 Terumo Corporation 9.11 List Not Exhaustive 10. Future of the Market

B. Braun Melsungen Ag, Baxter International Inc, Becton, Dickinson And Company, Carefusion Corporation, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic, Inc., Pfizer Inc., Smiths Medical, Terumo Corporation